Addex Therapeutics Income Statement (2022-2025) | ADXN

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B
Operating items
Research & Development -0.00B-0.01B-0.00B0.02B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B
Selling, General & Administrative -0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Other Operating Expenses 0.000.000.02B0.000.01B0.01B
Operating Expenses -0.01B-0.01B-0.00B0.03B-0.00B-0.00B-0.00B0.01B-0.00B-0.00B-0.00B0.01B-0.00B-0.00B-0.00B
Operating Income -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
EBIT -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Non-operating items
Interest & Investment Income 102.87212.850.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B3.62
Non Operating Income -0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B
Net income details
EBT -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Profit After Tax -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.00B-3536.88B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B
Equity Income -0.00B-0.00B-0.00B942.58B-0.00B-0.00B
Net Income - Minority -0.01B-0.00B-0.01B
Income from Continuing Operations -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Consolidated Net Income -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.01B-0.00B0.02B-0.00B-0.00B-0.00B0.00B
Income towards Parent Company -0.01B-0.01B-0.00B0.00B-0.00B-0.00B-0.00B-0.01B-0.00B0.02B-0.00B-0.01B-0.00B0.00B
Net Income towards Common Stockholders -0.01B-0.01B-0.00B0.00B-0.00B-0.00B-0.00B-0.01B-0.00B0.02B-0.00B-0.01B-0.00B0.00B
Additional items
EPS (Basic) -0.00B-0.01-0.01-0.14-0.00B-0.01-0.02-0.14B-0.00B-0.02-0.01
EPS (Weighted Average and Diluted) 0.11B-0.00B-0.24B
Shares Outstanding (Weighted Average) 0.08
Shares Outstanding (Diluted Average) 0.140.060.05
EBITDA -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Interest Expenses -0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-700.01-955.41-0.00B0.00B-0.00B0.00B-0.00B